HLA-ABC antibody

Catalog No. ABIN601549

This Mouse Monoclonal antibody specifically detects HLA-ABC in FACS, IP, IHC (fro), IHC and ELISA. It exhibits reactivity toward Human, Cow, Baboon, Cynomolgus, Macaque, Cat, Shrew and Monkey.

Quick Overview for HLA-ABC antibody (ABIN601549)

Target: HLA-ABC

Reactivity: Human, Cow, Baboon, Cynomolgus, Macaque, Cat, Shrew, Monkey

Host: Mouse

Clonality: Monoclonal

Conjugate: This HLA-ABC antibody is un-conjugated

Application: Flow Cytometry (FACS), Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (IHC), ELISA

Product Details anti-HLA-ABC Antibody

Specificity: Recognizes an antigenic determinant shared among products of the human HLA A, B and C loci. Recognizes a conformational epitope, reacting with HLA class I alpha3 and alpha2 domains.

Purification: Protein G purified

Endotoxin Level: Low Endotoxin

Immunogen: Purified human tonsil lymphocyte membranes.

Type of Immunogen: Cells

Isotype: IgG2a

Application Details

Application Notes: Approved: ELISA, Flo (1:50 - 1:100), IHC, IHC-Fr, IP

Usage: Suitable for use in ELISA, Flow Cytometry, Immunohistochemistry and Immunoprecipitation. Flow Cytometry: 1:50-1:100, 10 μL labels 10^6 cells in 100 μL. Immunohistochemistry: frozen sections. The applications listed have been tested for the unmodified form of this product. Other forms have not been tested.

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: PBS,  pH 7.4. No preservative added. Endotoxin Level: <0.01 EU/ug

Preservative: Without preservative

Handling Advice: Aliquot to Avoid repeated freezing and thawing.

Storage: 4 °C,-20 °C

Storage Comment: May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.

Target Details for HLA-ABC

Target: HLA-ABC

Alternative Name: HLA-A/B/C

Pathways: TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints